DuPont Powers AI and Next-Gen Electronics with Advanced Interconnect Innovations at JPCA Show 2025
TOKYO , June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at the Tokyo Big Sight East Exhibition Halls. At Booth #6C-03, DuPont will showcase its extensive portfolio of advanced interconnect solutions, which encompass fine line, signal integrity, power and thermal management.
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now
Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.
DuPont Achieves 100% Renewable Electricity in EU Operations
DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.
DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications
DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.
DuPont Expands Bioprocessing Portfolio with Launch of DuPont™ AmberChrom™ TQ1 Chromatography Resin
Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications WILMINGTON, Del. , May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioprocessing portfolio with the launch of DuPont™ AmberChrom™ TQ1 chromatography resin for the purification of oligonucleotides and peptides in support of a wide-range of biopharma applications.
Pessimism Overdone? 2 Recession-Resistant Dividend Stocks To Reward Long-Term Investors
The market has recovered most of its losses from last month's correction, and many quality stocks appear expensive again, prompting some investors to wait for another correction. DuPont de Nemours, Inc. offers 27% upside potential, a safe 2%+ yield, and strong fundamentals, with growth expected as macro conditions improve and a segment spin-off ahead. PepsiCo, Inc. faces near-term headwinds and slow growth, but its 4% yield, robust balance sheet, and transition to healthier products offer long-term upside.
DuPont and Epicore Biosystems Collaborate to Advance Worker Safety Through Smart Wearable Technology
CAMBRIDGE, Mass. and WILMINGTON, Del.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE:DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
DuPont Unveils Brand Identity for Qnity, Future Electronics Spin-Off
Qnity™ Branding Symbolizes the Power of Innovation and Partnership WILMINGTON, Del. , May 14, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today unveiled the branding of Qnity, the planned independent Electronics public company that will be created through the intended spin-off of its Electronics business*.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE:DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of DuPont de Nemours, Inc. – DD
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
